These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11709096)

  • 1. Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challenge.
    Wade-Evans AM; Stott J; Hanke T; Stebbings R; Berry N; Lines J; Sangster R; Silvera P; Walker B; MacManus S; Davis G; Cowie J; Arnold C; Hull R; Almond N
    AIDS Res Hum Retroviruses; 2001 Nov; 17(16):1517-26. PubMed ID: 11709096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.
    Couillin I; Letourneur F; Lefèbvre P; Guillet JG; Martinon F
    Virology; 2001 Jan; 279(1):136-45. PubMed ID: 11145897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from pathogenic SIV challenge using multigenic DNA vaccines.
    Haigwood NL; Pierce CC; Robertson MN; Watson AJ; Montefiori DC; Rabin M; Lynch JB; Kuller L; Thompson J; Morton WR; Benveniste RE; Hu SL; Greenberg P; Mossman SP
    Immunol Lett; 1999 Mar; 66(1-3):183-8. PubMed ID: 10203053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
    Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.
    Michelini Z; Negri DR; Baroncelli S; Catone S; Comini A; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Rovetto C; Liljestrom P; Norley S; Heeney J; Titti F
    J Med Primatol; 2004 Oct; 33(5-6):251-61. PubMed ID: 15525326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
    Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated SIV vaccines are not effective in a postexposure vaccination model.
    Linhart H; Gundlach BR; Sopper S; Dittmer U; Mätz-Rensing K; Kuhn EM; Müller J; Hunsmann G; Stahl-Hennig C; Uberla K
    AIDS Res Hum Retroviruses; 1997 May; 13(7):593-9. PubMed ID: 9135877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques.
    Muthumani K; Bagarazzi M; Conway D; Hwang DS; Ayyavoo V; Zhang D; Manson K; Kim J; Boyer J; Weiner DB
    J Med Primatol; 2002 Aug; 31(4-5):179-85. PubMed ID: 12390540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
    Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
    J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.
    Demberg T; Boyer JD; Malkevich N; Patterson LJ; Venzon D; Summers EL; Kalisz I; Kalyanaraman VS; Lee EM; Weiner DB; Robert-Guroff M
    J Virol; 2008 Nov; 82(21):10911-21. PubMed ID: 18753198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.
    Johnson RP; Glickman RL; Yang JQ; Kaur A; Dion JT; Mulligan MJ; Desrosiers RC
    J Virol; 1997 Oct; 71(10):7711-8. PubMed ID: 9311855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone.
    Stolte-Leeb N; Bieler K; Kostler J; Heeney J; Haaft PT; Suh YS; Hunsmann G; Stahl-Hennig C; Wagner R
    Viral Immunol; 2008 Jun; 21(2):235-46. PubMed ID: 18476770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.
    Fuller DH; Simpson L; Cole KS; Clements JE; Panicali DL; Montelaro RC; Murphey-Corb M; Haynes JR
    Immunol Cell Biol; 1997 Aug; 75(4):389-96. PubMed ID: 9315483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.
    Someya K; Xin KQ; Matsuo K; Okuda K; Yamamoto N; Honda M
    J Virol; 2004 Sep; 78(18):9842-53. PubMed ID: 15331719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.